GSK narrows earnings guidance after Shingrix boost

1st November 2018 Uncategorised 0

GSK says it now expects full-year earnings at the upper end of its guidance after continued sales growth during the third quarter and the delay to generic competition for one of its key products.

More: GSK narrows earnings guidance after Shingrix boost
Source: News